Presentations & Publications Categories ADXS-HER2ADXS-HOTADXS-NEOADXS-PSAHPV Related CancersLm Technology Presentation Combination Lm-LLO Immunotherapy plus Radiation Delays Tumor Progression and Prolongs Survival in Osteosarcoma UPLOADED: June 8, 2015 Publication Anti-Tumor Therapeutic Effects in Mice Treated With Listeria Monocytogenes (Lm)-LLO Immunotherapy In Combination with anti–PD-L1 UPLOADED: April 21, 2015 Presentation AACR 2015 Reception Presentation with Late Breaking Poster UPLOADED: April 19, 2015 Presentation AACR 2015 Reception Presentation with Late Breaking Poster UPLOADED: April 19, 2015 Presentation AACR 2015 Reception Presentation with Late Breaking Poster UPLOADED: April 19, 2015 Publication Listeria vaccines join the checkpoint frenzy. UPLOADED: December 1, 2014 Publication Lm-LLO Immunotherapies Targeting Multiple Antigens and Their Impact on Different Mechanisms in the Tumor Microenvironment UPLOADED: November 10, 2014 Presentation A recombinant HER2/Neu expressing Listeria monocytogenes (Lm9LLO) immunotherapy delays metastatic disease and prolongs overall survival in a spontaneous canine model of osteosarcoma UPLOADED: November 10, 2014 Publication Lm-LLO Immunotherapies Targeting Multiple Antigens and Their Impact on Different Mechanisms in the Tumor Microenvironment UPLOADED: November 10, 2014 Publication Episomal expression of truncated listeriolysin O in LmddA-LLO-E7 vaccine enhances antitumor efficacy by preferentially inducing expansions of CD4+ FoxP3- and CD8+ T cells UPLOADED: May 28, 2014 Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Next page next › Last page last »
